Stiripentol-d9 – 1 mg

Brand:
Cayman
CAS:
1185239-64-8
Storage:
-20
UN-No:
Non-Hazardous - /

Stiripentol-d9 is intended for use as an internal standard for the quantification of stiripentol (Item No. 17781) by GC- or LC-MS. Stiripentol is a third-generation antiepileptic compound.{28852} It is a positive allosteric modulator of GABAA receptors, potentiating GABA-mediated activation to a greater extent in receptors expressing α3 subunits and to a lower extent in those containing β1 or ε subunits.{48495} It also inhibits GABA reuptake in vitro and increases the release of GABA in neonatal rat hippocampal slices.{28852,48496} Stiripentol (500 µM) inhibits lactate dehydrogenase (LDH), blocking both lactate-to-pyruvate and pyruvate-to-lactate conversions by human LDH1 and LDH5.{28811} Formulations containing stiripentol have been used in the adjunctive treatment of seizures associated with Dravet syndrome.  

 

Available on backorder

SKU: 28506 - 1 mg Category:

Description

An internal standard for the quantification of stiripentol by GC- or LC-MS


Formal name: 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-d3-1-penten-5,5,5-d3-3-ol

Synonyms: 

Molecular weight: 243.3

CAS: 1185239-64-8

Purity: ≥99% deuterated forms (d1-d9)

Formulation: A solid